Based on the effects of a selective experimental zinc deficiency in a rodent model we explore the use of transcriptome profiling for assessing nutrient-gene interactions in the liver at the molecular and cellular levels. Zinc deficiency caused pleiotropic alterations in mRNA/protein levels of hundreds of genes. In the context of observed metabolic alterations in hepatic metabolism, possible mechanisms are discussed for how a low zinc status may be sensed and transmitted into changes in various metabolic pathways. However, it also becomes obvious that analysis of such complex nutrient-gene interactions beyond the descriptional level is a real challenge for systems biology.
Introduction
Gene-nutrient interactions represent the paradigm for the interplay between the rather static genome and the rapidly changing environment. Nutrigenomics was coined as a reference for the research in this interface between nutrition and cellular/genetic processes. There can be no doubt that molecular nutritional science is going to be of central interest to post-genomic research as nutrients and other food components are key factors in modulating gene and protein activities. A wealth of genetic information and novel techniques with high throughput capabilities provide fantastic new tools for nutrition and biomedical research (Hirschi et al., 2001) . Knowledge of the response of mammalian organisms to changes in their nutritional environment may be gathered at the mRNA and/or protein levels not only by expression arrays, proteome analysis and high throughput metabolite profiling, but also by systematic promoter analysis and by a spectrum of transgenic approaches with targeted gene inactivation or overexpression in cells or complex organisms (Stierum et al., 2001; Muller and Kersten, 2003) .
With the toolbox of the 'omics', nutritional science has become a new adventure in understanding metabolic processes in health and disease at the molecular level (Muller and Kersten, 2003) . Essentially every nutritional process relies on the interplay of a large number of proteins encoded by the respective mRNA molecules that are expressed in a certain cell, organ or organism. Alterations of mRNA levels and in turn of the corresponding protein levels (although this does not necessarily change in parallel) are critical parameters in controlling the flux of a nutrient or metabolite through a biochemical pathway. Nutrients and non-nutrient components of foods, diets and lifestyle can affect every step in the flow of genetic information from control of gene expression to regulation of protein synthesis and protein degradation and thereby alter metabolic functions in the most complex ways (Jump et al., 1990; Seguin and Hamer, 1987; Maxwell et al., 2003; Hamel et al., 2003) . As an example for the complexity of nutrient-dependent gene regulation, we describe here studies that assess the hepatic changes of the transcriptome and proteome in an animal model of experimental zinc deficiency.
How do nutrients affect gene expression in general?
During the evolution of mammals it was essential to life to adapt quickly to changes in the nutritional environment while maintaining metabolism to satisfy all needs and to provide a continuous production of ATP. The adaptation to food availability (energy as well as individual nutrients) requires very fast but also sustained responses that simultaneously change a huge set of interconnected metabolic processes. This is mainly achieved by hormones that can be classified by their chemical nature (i.e. peptide hormones or steroids) and/or the mode and time frame of their action. When looking at the effects of diet on gene expression, nutrients such as carbohydrates, lipids, proteins or calcium, which are directly involved in hormone secretion and action, have to be separated from those dietary constituents that appear not to be directly embedded in these hormonal circuits and signaling processes such as certain vitamins or minerals (Roth and Kirchgessner, 1994; ). However, with regard to hormone-mediated alterations in cellular metabolism, changed patterns (concentrations) of individual nutrients/metabolites in a cell can in addition to the hormones affect gene expression by interaction with specific targets including nuclear receptors and response elements as depicted in Figure 1 . The lack of an essential nutrient causing a sustained deficiency syndrome can also secondarily alter hormone secretion and action and thereby affect gene expression directly and indirectly in the most complex ways (Roth and Kirchgessner, 1994; Ninh et al., 1995 Ninh et al., , 1998 .
The role of the essential trace element zinc in metabolism
Zinc (Zn) belongs to the most abundant elements in mammalian organisms, with around 85% of the body content found in muscle and bone (Pallauf and Kirchgessner, 1972) . Zinc intake and bioavailability vary considerably depending on the dietary source, with a mean daily intake of 10 to 15 mg (Lonnerdal, 2000; Briefel et al., 2000) . Almost all zinc is found intracellularly, with 50% in the cytosol and vesicles and 30 to 40% contained in the nucleus (Alfaro and Heaton, 1974) . Zinc is almost completely bound to proteins and nucleic acids or chelated by low molecular weight ligands, leading to a very low concentration of the free ionized species (Frederickson, 1989; Paski et al., 2003) . In the form of its complexes with proteins and nucleic acids it participates in a huge number of processes of intermediate metabolism, regulation of gene expression, storage, synthesis and action of peptide hormones as well as in the structural maintenance of chromatin and biomembranes (Boquist et al., 1968; Bettger and O'Dell, 1981; Figlewicz et al., 1984; Mazus et al., 1984) .
Zinc has been shown to be essential for both catalytic and structural functions of a large number of macromolecules including over 300 enzymes. Numerous metalloproteins, including members of oxido-reductase, hydrolase, ligase and lyase families, are zinc dependent and it also co-activates copper enzymes such as phospholipase C or superoxide dismutase (SOD) (Coleman, 1992; Vallee and Falchuk, 1993) . Although zinc does not directly participate in redox reactions, it contributes to the protection of biological structures from damage by free radicals (Pearce et al., 2000; Powell, 2000) . This may be mediated in the first place by its effects on the expression level of metallothioneins (MTs) that act secondarily as free radical scavengers or by its co-activation function in SOD, which protects cellular thiols and reduces the generation of free radicals from iron-dependent processes (Maret, 1994 (Maret, , 1995 Maret and Vallee, 1998; Maret et al., 1999) . These functions become apparent during zinc deficiency, with markedly increased levels of lipid peroxidation in plasma membranes as well as in mitochondrial and microsomal membranes. This leads, for example, to an increased fragility of erythrocyte membranes and an impaired homeostasis of platelets (Sullivan et al., 1980; Bettger and O'Dell, 1981; Bray and Bettger, 1990; Oteiza et al., 1995) .
As Zn-ATP, the element is necessary for synthesis of coenzymes such as pyridoxal-5-phosphate and FAD; both are required for hundreds of enzymatic reactions (Churchich et al., 1988 (Churchich et al., , 1989 . Zinc is also involved in tubulin polymerization and actin filament formation and stabilization (Avery and Bettger, 1992; Wolf et al., 1993; Southwick et al., 2003) . A decreased T-cell number and altered responses of T-lymphocytes to phytomitogens are indicators of a zinc deficiency in the immune system (Allen et al., 1983; Beck et al., 1997; Bao et al., 2003) . Endogenous zinc appears to modulate GABA-mediated synaptic transmission and can block Cachannels at the presynaptic level, causing inhibition of neurotransmitter release (Winegar and Lansman, 1990; Harrison and Gibbons, 1994; Takeda et al., 2003) .
Zinc participates in gene expression control
In zinc finger motifs, the metal provides a scaffold that organizes protein sub-domains for the interaction with either DNA or other proteins (Klug and Rhodes, 1987; Klug, 1999) . Zinc finger motifs are the most common recurring motif in transcription factors, with the 'finger' structure determined by the single zinc atom at its base that allows specific binding to DNA through the resulting conformation. Such motifs have been identified in various nuclear hormone receptors for steroids, thyroid hormones and vitamin D (Favier, 1992; Vallee and Falchuk, 1993; Meier, 1997) . Since low zinc levels inhibit cell division and growth and high zinc levels are toxic, cells must maintain an intracellular zinc content within a narrow concentration range. Metallothioneins (MTs) are essential to intracellular zinc homeostasis by sequestration of the metal and thereby controlling available free zinc (Sato et al., 1984; Beyersmann and Haase, 2001; Coyle et al., 2002) . The cysteine sulfur ligands in the cluster structure of MTs can be oxidized and reduced with concomitant changes in bound zinc (Maret, 1994 (Maret, , 1995 Maret and Vallee, 1998; Maret et al., 1999) . There are four known functional MT genes, MT-I to MT-IV, that show different expression patterns (Ebadi et al., 1995; Vallee, 1995) . The prime function of MT-I and MT-II is to detoxify heavy metals, regulate zinc and copper homeostasis and to limit oxidative damage in cells (Hamer, 1986; Palmiter, 1998) . Expression levels of MT proteins are quickly altered in response to stress and via the transcriptional regulation of gene expression by the metals (Andrews, 2000; DeMoor and Koropatnick, 2000; .
Much of our basic understanding of zinc-regulated gene expression comes from studies in bacteria and yeast. In Escherichia coli (Brocklehurst et al., 1999; Outten et al., 2001) , Bacillus subtilis (Gaballa and Helmann, 1998; Gaballa et al., 2002) and Saccharomyces cerevisiae (Zhao and Eide, 1997; Jamison McDaniels et al., 1999; Daniels et al., 2002; Bird et al., 2003) a large number of genes were identified encoding metallo-regulatory proteins that act as zinc sensors and transcriptional activators and/or repressors. Zinc finger-containing transcription factors not only regulate 'zinc-sensitive' genes, but also control their own transcription through a positive autoregulatory mechanism (Lyons et al., 2000) . In mammalian cells, the metal responsive transcription factor 1 (MTF-1) was recognized as an important zinc sensory transcriptional activator. MTF-1 binds to zinc-sensing gene promoter elements, also known as metal responsive elements (MRE), and induces gene transcription of key target genes such as MT-I and MT-II. Interestingly, disruption of the MTF-1 gene in mice is lethal, whereas animals lacking both MT-I and MT-II are viable. This suggests that MTF-1 controls the expression of many more important genes in addition to MT-I and MT-II Andrews et al., 2001) . Very recently, MTF-2, an ortholog of MTF-1, was identified as another zinc-dependent transcription factor (Cousins et al., 2003 ). There appears to be a huge number of 'zinc-regulated' genes in all organisms and it remains to be determined how zinc availability in a cell controls target gene transcription directly or secondarily by indirect mechanisms (Beyersmann and Haase, 2001 ).
Assessing zinc deficiency at the transcriptome level
To identify genes in mammalian cells that show altered mRNA expression levels in zinc deficiency, we have used a rat model and determined organ-specific changes in mRNA profiles by oligonucleotide arrays containing 5535 target sequences (Pan ᮋ 5K Pan rat oligonucleotide array; MWG Biotech, Ebersberg, Germany). A list with regulated mRNA species identified by transcriptome analysis and proteins identified by proteome analysis that are discussed here in the context of zinc-dependent metabolic alterations is provided as online supplementary material (www.nutrition.tum.de/genelist/TD5kPAN.htm). All methods referring to the analysis of the transcriptome and proteome have been published recently (tom Dieck et al., 2003; Herzog et al., 2004) .
Zinc deficiency in the rat model was achieved by forcefeeding intragastrically four times per day a diet made zinc deficient (providing 1.3 mg Zn/kg diet) or a control diet (providing 25 mg Zn/kg) for 11 days as described (Roth, 2001) . Zinc status was assessed by the serum zinc concentrations as determined by atomic absorption spectroscopy and by the activity of serum alkaline phosphatase (EC 3.1.3.1) as described (Roth, 2001; tom Dieck et al., 2003) . Serum zinc decreased from 24.0"2.4 to 9.9"1.7 mmol/l and serum alkaline phosphatase activity was reduced from 380"61.7 to 238"58.6 U/l at the end of the 11 days of dietary treatment. Animals receiving the zinc-deficient diet showed reduced growth and weight gain (around 10%) despite an identical caloric and macronutrient intake as in controls (tom Dieck et al., 2003) . Different tissues of zinc deficient and control animals were submitted to mRNA profiling employing microarrays with the confirmation of almost a hundred target genes for changes in expression levels by Northern blot analysis or light cycler-based RT-PCR. In addition, we performed proteome analysis of selected tissues by means of 2-dimensional gel electrophoresis and peptide mass finger printing via MALDI-TOF-MS as described by Herzog et al. (2004) . Among the tissues and organs investigated, liver showed the most pronounced changes with a huge number of transcripts and proteins affected in steadystate expression level.
From growth control to metabolism
The zinc status in mammals is known to affect growth and this is mediated at least in part through the somatotropic axis with alterations in the level of circulating insulin-like growth factor I (IGF-I) (McNall et al., 1995; Ninh et al., 1995; Lefebvre et al., 1998 Lefebvre et al., , 1999 Ninh et al., 1998) . Correspondingly, seven of the identified hepatic transcripts with reduced expression levels in zinc-deficient rats related to liver targets of growth regulation including the growth hormone receptor (GHR), the GHR binding protein (GHRBP), IGF-I, the IGF binding proteins IGFBP1 and IGFBP2 and a subunit of IGFPB (tom Dieck et al., 2003) . A decreased level of circulating IGF-1 and a blunted hepatic response to growth hormone (GH) have been reported for rats in almost identical experimental models of zinc deficiency (Roth and Kirchgessner, 1994) , suggesting that the growth retardation observed in our zinc-deficient animals is caused-at least in part-by the impaired transcription of a whole set of the liver-specific target genes of the GH axis.
Thyroid hormones also affect growth, and it appears that zinc also influences the biological function of the thyroid hormones and their receptors, but the mechanism by which zinc acts on the thyroid axis is not yet clear (Freake et al., 2001) . Our analysis revealed a significant up-regulation of the thyroxine deiodinase type I mRNA in liver, which may lead to an increase in the protein product that deiodinates thyroxine to triiodothyronine (T3). A markedly increased activity of hepatic deiodinase and altered circulating T3 levels have indeed been reported in zinc-deficient rats (Oliver et al., 1987) , suggesting that there might be an increased overall thyroid hormone activity. However, zinc deficiency was also shown to affect intracellular thyroid hormone signaling by changing the ability of the hormone receptor to bind to the DNA (Miyamoto et al., 1991) and thereby alter target gene transcription rates. Figure 2 provides a simplified model for how Zn deficiency can alter hepatic processes that in turn affect circulating hormone concentrations and alter liver function as a prime target organ for the action of these hormones.
One of the T3-responsive genes in liver is the lipogenic factor S14 and expression of the S14 gene was markedly increased in zinc-deficient rats. This gene was first investigated because of its rapid response in gene expression to T3 in rat liver and primary hepatocytes (Jump and Oppenheimer, 1985) . S14 is only expressed in tissues active in lipogenesis and its transcript levels are not only dependent on T3, but also controlled by other stimuli such as carbohydrates (via carbohydrate-responsive elements; ChoREs) that in turn modulate fatty acid synthesis in rodent liver (Koo and Towle, 2000) . S14 is mainly found in the perivenous portion of the hepatic lobule as the main site of fatty acid synthesis and is critical for the induction of key enzymes involved in the switching of hepatic metabolism from the fasted to the fed state (Cunningham et al., 1998) . Does the increased S14 mRNA level in rat liver as observed here in zinc deficiency lead to concomitant changes in hepatic fat metabolism?
Data from the microarray analysis indicated not only changes in the S14 mRNA level but also a variety of transcripts coding for proteins of hepatic fat and glucose metabolism (Figure 3 ). Enzymes required for triglyceride or phospholipid breakdown and either mitochondrial or peroxisomal fatty acid degradation uniquely displayed reduced mRNA levels, whereas those responsible for fatty acid synthesis and triglyceride assembly showed increased message levels. Similarly, the transcript levels of proteins required for fatty acid translocation through the inner mitochondrial membrane were reduced, whereas those required for delivery of acetyl-CoA to the cytosolic fatty acid synthesis showed elevated mRNA levels. Moreover, the liver fatty acid-binding protein (L-FABP) mRNA was increased 3-fold, whereas the fatty acid transporter protein mRNA decreased about 3-fold. This all suggested major changes in hepatic fat metabolism and lipid sequestration toward an increased fatty acid de novo synthesis followed by triglyceride formation with a simultaneously reduced rate of triglyceride hydrolysis and reduced rate of fatty acid degradation and oxidation. These predicted alterations in hepatic fat metabolism during zinc deficiency have indeed been observed with an increased activity of the fatty acid synthase complex and an enhanced triglyceride accumulation in rats made zinc deficient in force-feeding experiments as used here (Table 1) .
Impaired hepatic glucose metabolism
Proteins involved in hepatic glucose metabolism also showed major changes in mRNA levels, including transporters and enzymes that control glycolytic and gluconeogenic fluxes (see gene list provided as supplementary material). The mRNA levels of the insulin receptor, the glucose transporter (GLUT-2) and the catalytic subunit of the Glucose-6-phosphatase (G6Pase) were reduced about 2-fold. The latter is a multifunctional enzyme embedded within the ER membrane that possesses both catalytic and substrate/product transport activities to release glucose from hepatic glycogen breakdown and from gluconeogenesis (Hah et al., 2002; Foster and Nordlie, 2002; Barthel and Schmoll, 2003) . The counterpart of G6Pase in the glycolytic chain is glucokinase (GK) which mediates glucose-6-phosphate production. Most interestingly, in our zinc-deficient rats, the glucose kinase regulatory protein (GCKR) mRNA showed a 2.5-fold increase, suggesting that GK, which is allosterically regulated by GCKR, may display a reduced activity. The second flux-controlling enzyme in the glycolytic pathway is the phosphofructokinase (PFK) that converts fructose-6-phosphate into fructose-1,6-bisphosphate (F1,6P), and PFK is regulated by fructose-2,6-bisphosphate (F2,6P). A bifunctional enzyme, the phosphofructo-2-kinase:fructose-2,6-bisphosphatase (PF2K:F2,6Pase) catalyzes the synthesis and degradation of F2,6P, and this metabolite is not only the most potent activator of PFK but also an inhibitor of fructose-1,6-bisphosphatase. In this way PF2K:F2,6Pase mediates a switching mechanism in glycolysis/gluconeogenesis opposing fluxes. The activity of the hepatic PF2K:F2,6Pase is reciprocally regulated by the cyclic AMP-dependent protein kinase (cAMP-PK)-catalyzed phosphorylation at Ser32, and phosphorylation of this residue inhibits the kinase and simultaneously activates the bisphosphatase. F-2,6-Pase has also been shown to be inhibited by both F2,6P and F6P (for a review see Goldstein and Maevsky, 2002) . We have observed here that the PF2K:F2,6Pase protein levels in livers from zinc-deficient rats are significantly reduced and together with the reduced level of the insulin receptor mRNA an impaired signaling in the control of the switching processes that inversely regulate glycolysis and gluconeogenesis has to be postulated.
Another level of regulation of these pathways of glucose metabolism in liver may involve a zinc binding protein. PFK was shown to physically interact with an A simplified model for the effects of Zn deficiency on hepatic processes that in turn affect circulating hormone levels of the GH, IGF, insulin and thyroid axis and with the liver as a target organ for the action of these hormones. Postulated impairments in signaling cascades that secondarily affect hepatic gene transcription are indicated.
Figure 3
Alterations of hepatic metabolism in zinc deficiency. Metabolic processes and individual enzymatic reactions in hepatic carbohydrate and fat metabolism that responded with significant changes ()2-fold) in transcript/protein levels to experimental Zn deficiency in the rat model. Open boxes indicate proteins (enzymes) with lowered transcript/protein levels, filled boxes those with increased levels, circles indicate the relevant transport proteins. For interpretation see text and Table 1. 11.5 kDa Zn binding protein (ZnBP) that can cause an inhibition of its catalytic activity (Trompeter and Soling, 1992) . The rat ZnBP gene was suggested to be a downstream target gene of the metal-transcription factor 1 ), but strikingly, the hepatic ZnBPmRNA showed a more than 5-fold increase in expression level in our zinc-deficient rats. Whether ZnBP is functionally active under these conditions is not known and therefore its effect on PFK activity cannot be predicted. However, ligand affinity chromatography with ZnBP has, in addition to PFK, identified the glycolytic enzymes hexokinase/ glucokinase and L-type pyruvate kinase as well as the gluconeogenic enzymes fructose-1,6-bisphosphatase and the bidirectional enzymes aldolase and glycer- Cunnane et al. 1988 Increased hepatic fat content (68%), increased levels of lauric, myristic, myristroleic, palmitic, Eder and Kirchgessner, 1993 palmitoleic and oleic acid and decreased arachidonic acid level in livers of force-fed animals Higher n-3 (mainly eicosapentanoic acid) and lower linoleic acid contents in livers of force-fed Eder and Kirchgessner, 1994a animals Fatty livers in animals fed coconut-oil, lower total n-6 and particular linoleic and arachidonic Eder and Kirchgessner, 1994b acid levels in liver phospholipids in force-fed animals Reduction in D9 desaturase activity in liver microsomes, increased ratio of saturated to Eder and Kirchgessner, 1995b monounsaturated fatty acids in liver phospholipids and microsomes in force-fed animals Reduced level of n-6 PUFA, impaired D5 and D6 desaturation, impaired desaturation of Eder and Kirchgessner, 1996 linoleic acid in force-fed animals aldehyde-3-phosphatase as interacting partners of the liver ZnBP (Brand and Heinickel, 1991) . This strongly argues for a pleiotropic regulatory role of ZnBP in the control of substrate fluxes through the metabolic chains of glycolysis and gluconeogenesis. Assuming that the protein levels change in parallel to the mRNA levels of these enzymes, hepatic carbohydrate metabolism should show major alterations in zinc deficiency, both by changed protein steady-state levels as well as by changed concentrations of important allosteric regulators such as fructose-2,6,-bisphosphate. Evidence for a disturbed hepatic glucose metabolism comes from studies in zinc-deficient rats and in metallothionein-deficient mice ( Table 1 ). The basal hepatic glucose production in Zn-depleted rats for example was shown to be reduced (Faure et al., 1991) and in addition, MT-null mice with a low Zn concentration in liver also showed a reduced hepatic gluconeogenesis upon stimulation (Rofe et al., 1996) . Moreover, a reduced rate of glycolysis was shown in isolated hepatocytes from MT y/y mice in comparison to cells obtained from control animals (Rofe et al., 1996 (Rofe et al., , 2000 . Our findings based on hepatic transcriptome analysis suggest that Zn deficiency alters glucose utilization and glucose release in hepatocytes through a quite complex regulatory network including regulation at the transcriptome and protein levels, by protein-protein interactions and by allosteric and kinetic effects.
Are there indications for a common control mechanism in gene expression for enzymes of hepatic glucose metabolism and enzymes that mediate the increased lipid accumulation? As addressed above, the lipogenic factor S14 plays a central role in expression of a variety of lipogenic enzymes. The S14 gene shares significant sequence homology with the liver-type pyruvate kinase and fatty acid synthase (FAS) genes in control elements (Jump et al., 1994) , and all three genes displayed increased expression level and protein activity in Zn-deficient animals. Moreover, S14 and FAS genes possess a carbohydrate responsive element (ChoRE) that could confer the glucose responsiveness in gene expression (Shih and Towle, 1994; Koo and Towle, 2000) . Whether the impaired hepatic glucose metabolism in Zn-depleted animals secondarily alters the ChoRE-mediated control of gene expression is not known, but further studies may explore these three genes with common motifs for an immediate transcriptional link between hepatic fat and carbohydrate metabolism.
From fatty acids to oxidative stress
The sterol regulatory element binding protein-1c (SREBP-1c) has also emerged as a major transcription factor involved in the regulation of lipogenesis. Responses of the lipogenic enzymes such as glycerol-3-phosphate acyltransferase, ATP citrate lyase, malic enzyme and S14, which showed altered expression here in Zn deficiency, were completely abolished in SREBP-1 y/y mice (Shimano et al., 1999; Foretz et al., 1999) . SREBP-1c is a basic helix-loop-helix-leucine zipper transcription factor. A 125 kDa precursor (pSREBP-1c) is first attached to the endoplasmic reticulum and after proteolytic processing in the Golgi, the active form, nSREBP1c (65 kDa), accumulates in the nucleus. There it binds sterol regulatory elements (SRE) in the promoters of many genes involved in fatty acid and triglyceride synthesis (Wang et al., 1994) . Transcription of the SREBP1c gene is induced by insulin (Kotzka et al., 1998; Ducluzeau et al., 2001 ) and oxysterols through LXR (Repa et al., 2000) . Much of the insulin action on lipogenic gene transcription has been ascribed to the insulinmediated induction of SREBP-1c (Kotzka et al., 1998; Matsumoto et al., 2002) . In contrast, unsaturated fatty acids suppress the nuclear SREBP-1c levels and when nSREBP-1c is over-expressed in primary hepatocytes it eliminates the effects of polyunsaturated fatty acids (PUFA) on several lipogenic genes. This indicates that SREBP-1c is a key target for PUFA action on de novo lipogenesis (Mater et al., 1999; Moon et al., 2002) . In Zndeficient rats, the fatty acid composition of liver lipids changes substantially with a two-to three-fold rise in particular of a-linolenic, g-linolenic and eicosapentanoic acid concentrations (unpublished data) and similar changes have been observed in previous studies on zincdeficient rats (Eder et al., 1994) . Other changes in liver fatty acid composition include an accumulation of medium chain fatty acids such as lauric acid, myristic acid, myristoleic acid and palmitic acid (Table 1) , which might reflect their impaired oxidation via the mitochondrial pathway. Whether these hepatic changes in fatty acid concentrations and fatty acid pattern in turn alter gene expression of target genes remains to be determined. A key protein activated by PUFA serving as a ligand is the peroxisomal proliferator receptor a (PPAR-a), which in turn regulates together with retinoid X receptors (RXR) numerous hepatic genes encoding peroxisomal, microsomal and some mitochondrial fatty acid metabolizing enzymes as well as the fatty acid binding protein and fatty acid transporter (Jump et al., 1995; Peters, 1996; Clarke and Jump, 1997; Barclay et al., 1999; Motojima, 2000; Latruffe et al., 2000) . Although mice lacking a functional PPAR-a have no obvious phenotype on a normal diet, the animals accumulate massive amounts of lipid in livers when fasted or fed a high-fat diet (Kersten et al., 1999; Hashimoto et al., 2000) . PPAR-a is considered to serve as a molecular 'lipostat' factor by inducing the expression of target genes of fatty acid metabolism and stress response. Recently the physiological effects of seven different PPAR activating drugs have been examined in a rat model of dyslipidemia and comparative gene expression profiles were obtained to determine common genes controlled by PPAR activation. Almost all enzymes of peroxisomal and mitochondrial fatty acid b-oxidation, as well as FABP, that showed reduced mRNA expression in our Zn-deficient rats were found as uniformly up-regulated by the various PPAR agonists (Frederiksen et al., 2004) . Although this inverse regulation may just be by coincidence, a putative link may be that Zn is an essential element in PPAR-mediated gene transcription (Gearing et al., 1994) . PPAR normally binds to response elements (PPREs) within the 59-flanking regions of these genes as a heterodimer with the retinoid X receptor, RXR. PPREs contain a DR1 motif consisting of imperfect direct repeats of the nuclear receptor core recognition sequence (AGGTCA) separated by a single nucleotide. The repeated core recognition sequences interact directly with the amino terminal zinc finger of each nuclear receptor (Keller et al., 1995; IJpenberg et al., 1997; Hsu et al., 1998) .
Although not yet proven, it may be speculated that the same clusters of hepatic genes up-regulated by PPAR agonists and down-regulated in Zn deficiency are regulated by the zinc-dependent transcriptional activity of PPREs. This receives further support by the observation that a large number of cytochromedependent enzymes in rat liver showed markedly decreased steady state mRNA levels in Zn deficiency (Xu et al., 1994 (Xu et al., , 2001 tom Dieck et al., 2003) , whereas a sustained activation of PPAR-a by peroxisomal proliferators has been shown to increase their expression and to induce hepatocellular carcinomas in rats and mice (Johnson et al., 1996; Miller et al., 1996; Cui et al., 2001; Gonzalez, 2002; Meyer et al., 2002) . This peroxisome proliferator-induced carcinogenic effect has been attributed to the transcriptional activation of PPAR-a regulated genes and the resulting excessive generation of reactive oxygen species (ROS) -mainly of H 2 O 2 -that is produced as a byproduct mainly of the peroxisomal acylCoA oxidase (AOX) (Yu et al., 2003) . Since Zn deficiency caused the down-regulation of enzymes for fatty acid oxidation including the bifunctional oxidases and AOX, hepatocytes from Zn-deficient animals could have lower rates of H 2 O 2 production. A further reduction of H 2 O 2 levels could arise from the decline of copper/zinc-superoxide dismutase (SOD), which displayed a more than 3-fold reduced protein level in zinc-deficient rats. A lower activity of SOD, however, could cause increased superoxide anions levels, thereby causing a shift in the spectrum of hepatic reactive oxygen species. In this context it is interesting to note that glutathione peroxidase 1, a functionally important selenoprotein that catalyzes the inactivation of ROS and reactive nitrogen species, showed increased mRNA expression levels in Zn deficiency, suggesting a compensation mechanism for protection of hepatocytes from ROS-mediated damage during Zn deficiency (tom Dieck et al., 2003) . As addressed above, metallothioneins (MTs) are also considered to act as ROS scavengers and Zn deficiency caused an almost complete down-regulation of the MT-I mRNA in rat liver (Andrews et al., 1987; tom Dieck et al., 2003) that in turn could again increase the hepatic ROS burden. That gene expression of metallothioneins is not only dependent on the Zn status but also on oxidative stress has been established (Dalton et al., 1996; ) and one factor that links ROS status and MT expression could be the metal transcription factor 1. Next to the MT genes, MTF-1 also affects the expression of genes encoding proteins, i.e. for glutathionine synthesis and cellular zinc homeostatsis . A disequilibrium between Zn availability and ROS production may therefore, via MTF-1, cause some of the changes observed here in Zn deficiency. The contribution of W. Schaffner in this issue will address in detail the various biological functions of MTF-1.
One of the key questions related to the wide variety of effects of Zn deficiency on gene expression refers to the role of the numerous zinc-dependent transcription factors. Zinc fingers are found in around 2% of human genes and represent the most prominent form of DNAbinding domains in transcription factors. They are characterized by a short stretch of 30 amino acids containing two cysteines and two histidines that coordinate the zinc ions. This allows protein folding into a b-turn and an ahelix containing compact structure. Many of the transcription factors contain three or more fingers typically occurring in tandem arrays that allow in concert to recognize the DNA and direct the transcription factor to its appropriate promoter elements (for a review see: Klug, 1999; Jamieson et al., 2003) . To which extent an experimental zinc deficiency reduces the concentration of available zinc for coordination in Zn fingers is not known. Concentrations of free zinc in cells are difficult to determine but it has been suggested that they may vary between 10 y9 and 10 y4 M (Taki et al., 2004) . Zinc dissociation constants reported for naturally occurring zinc sites in various transcription factors fall in the range of 10 y11 to 10 y9 M and nuclear concentrations were proposed not to drop below 10 y12 M (Payne et al., 2003) . Zn deficiency usually reduces Zn contents in tissues only to about half of normal, but simultaneously, zinc-binding protein expression (i.e. MT-1) also drastically changes, which in turn affects zinc availability for biological processes. Whether zinc concentration at the site of its action in zinc fingers is also reduced, and thereby impairs transcriptional control in a more general way, is currently not known. For the majority of the alterations observed here on the hepatic transcriptome and proteome in Zndeficient rats, a meaningful interpretation of the data are therefore currently not possible and would represent even more a 'reading of tea leaves'.
Summary
Based on an example of a selective micronutrient deficiency we attempted to demonstrate that the analysis of nutrient gene interactions in a complex organism -even in a well defined experimental setting -is not a triviality. The described pleitropic alterations in the transcriptome/ proteome of a target tissue such as the liver provide a good example for the complexity of nutrient gene interactions. Based on just 5500 target sequences analyzed by the microarray-based screen, hundreds of genes could be identified that showed significant changes in mRNA expression levels. Identified functional gene/protein clusters with uniform changes in expression levels allowed predictions of major changes in metabolic pathways of hepatic carbohydrate and fat metabolism, as well as oxidative stress defense, that do have phenotypic correlates in clinical chemistry data from the same animal models of zinc deficiency. However, with the limited knowledge of gene regulation, of the interplay of protein networks, of the huge number of regulatory feedback loops and of the large number of zinc-dependent transcription factors, interpretation of microarray-and/or proteome-based data are currently very limited and therefore the majority of the gene regulation phenomena remain obscure. Taking into account human genetic heteroge-neity and the enormous variability in dietary intake of nutrients in humans, research on nutrient-gene interactions is clearly one of the most challenging exercises for 'systems biology'.
Although the new high-throughput methods allow us for the first time to analyze a physiological, pathological or pathobiochemical response of an organism to environmental changes by assessing the underlying alterations of the entire (or parts) transcriptome, proteome or metabolome, they clearly have their limitations. DNA array technology has been applied already in numerous studies to determine nutrient-gene interaction (Fischer et al., 2001; Maxwell et al., 2003) for a variety of nutritional factors including zinc Lyons et al., 2001) . The current value of DNA array use appears to be mainly that of a screening tool for identification of genes that show most pronounced changes in transcriptional regulation. Consequently, the results should be used as a starting point to generate a new hypothesis on gene regulation and to design more decisive experiments with confirmation of changes at mRNA and protein levels by independent methods and by combining them with biochemical/clinical endpoints.
